Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Food Allergy: early-phase trial registry
9 of 18 indexed Food Allergy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #953 of 28,707 conditions by registered trial count.
18 US clinical trials · 9 currently recruiting · #953 of 28,707 conditions by registered trial count
Food Allergy: 18 US clinical trials tracked, 9 recruiting.
Food Allergy is the subject of 18 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Allergy and Infectious Diseases (NIAID), running 2 of these trials.
Enrollment posture brief
Registry condition food-allergy
OPEN 9 | RECR 50% | LATE 2 | EARLY 10 | RANK #953 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Food Allergy lists 9 open slots (50% of 18 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Food Allergy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Food Allergy is recruiting above its size-band peers.
9 of 18 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Food Allergy trials is spread across many organizations.
National Institute of Allergy and Infectious Diseases (NIAID) accounts for 2 of 18 trials (11.1%). 17 distinct sponsors appear on at least one study for this condition label.
-
Most Food Allergy trials plan to enrol fewer than 100 people.
Median target enrolment is 73 among the 18 trials that report a genuine target (sentinel values excluded). 12 of those (66.7%) plan for fewer than 100 participants.
-
Food Allergy research is mostly interventional.
13 interventional and 5 observational studies make up this index (72.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
18 total, page 1 of 1
Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders
Children's Hospital Medical Center, Cincinnati
NCT00267501
Natural History and Genetics of Food Allergy and Related Conditions
National Institute of Allergy and Infectious Diseases (NIAID)
NCT02504853
Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site
Stanford University
NCT03539692
Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
University of Michigan
NCT06300697
Effect of Omalizumab in the Skin of Food Allergy Patients
National Jewish Health
NCT06618963
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
Rima Rachid
NCT05695261
PK/PD Study of IN-001 Sublingual Spray in Healthy Adults
Insignis Therapeutics
NCT07210320
Omalizumab Weight-Based Dosing Efficacy Trial
Massachusetts General Hospital
NCT06943534
Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy
Regeneron Pharmaceuticals
NCT06369467
Systems Biology of Early Atopy
National Institute of Allergy and Infectious Diseases (NIAID)
NCT04798079
FeNO as a Marker of Allergic Reactions to OFC and Response of OMA Treatment in Multiple FA
AAADRS Clinical Research Center
NCT06437171
Effects of Infant Egg Consumption on Child Health and Cognition Development
State University of New York at Buffalo
NCT04345185
Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy
Hugh A Sampson, MD
NCT01846208
Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy
Scott Sicherer
NCT03907397
ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults
Alladapt Immunotherapeutics
NCT04856865
Multi Immunotherapy to Test Tolerance and Xolair
Kari Christine Nadeau
NCT02626611
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
Boston Children's Hospital
NCT01781637
Preventing Anaphylaxis With Acalabrutinib
Johns Hopkins University
NCT05038904
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 6 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Food Allergy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Food Allergy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Food Allergy page
18 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 9 Food Allergy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most Food Allergy trials on record, review their full trial history before evaluating a specific study. See National Institute of Allergy and Infectious Diseases (NIAID)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Food Allergy condition card totals 18 registered trials; most-linked intervention Omalizumab; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.